share_log
Reuters ·  May 7 06:07
Day One Biopharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $40 From $50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment